BOT 4.76% 33.0¢ botanix pharmaceuticals ltd

Ann: BTX 1503 Acne Phase 2 Study Results Presentation, page-502

  1. 231 Posts.
    lightbulb Created with Sketch. 38
    The FDA will only look at safety from the p11 trial to consider approval not efficacy . The efficacy of the drug will be proven or otherwise by the P111 trial now we know some of the limitations in the data from the US from the P11 result.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
33.0¢
Change
0.015(4.76%)
Mkt cap ! $597.3M
Open High Low Value Volume
32.5¢ 33.5¢ 32.3¢ $1.265M 3.862M

Buyers (Bids)

No. Vol. Price($)
4 129446 32.5¢
 

Sellers (Offers)

Price($) Vol. No.
33.0¢ 131308 2
View Market Depth
Last trade - 16.10pm 09/08/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.